reference/27577586

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27577586

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	1189
issn	1468-2060 0003-4967
issueIdentifier	7
pageRange	1183-1189
publicationName	Annals of the Rheumatic Diseases
startingPage	1183
bibliographicCitation	Mease P, Strand V, Shalamberidze L, Dimic A, Raskina T, Xu LA, Liu Y, Smith J. A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate. Ann Rheum Dis. 2012 Jul;71(7):1183–9. doi: 10.1136/annrheumdis-2011-200704. PMID: 22328739.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e890d2671c21a491ecd938cf54a57d00 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3275d2fbe856b9fe950453643cc87771 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e52259b5733b956f357f8b509196f78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c6878cd6f25d2f52b18300667ef5f43 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae04e5d47951ccb6013c0a06c5ed86b0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7617b13a69dc978f25bae5f6de9ff9e7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d627ab6b1a44c599d3dc2b2d2e506d3a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d57b98b2a299b3b7d0970ee44a921ec
date	2012-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/22328739 https://doi.org/10.1136/annrheumdis-2011-200704
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/640 https://portal.issn.org/resource/ISSN/1468-2060 https://portal.issn.org/resource/ISSN/0003-4967
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A phase II, double-blind, randomised, placebo-controlled study of BMS945429 (ALD518) in patients with rheumatoid arthritis with an inadequate response to methotrexate
discusses	http://id.nlm.nih.gov/mesh/M0017460 http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0008658 http://id.nlm.nih.gov/mesh/M0542722 http://id.nlm.nih.gov/mesh/M0001067 http://id.nlm.nih.gov/mesh/M0027742 http://id.nlm.nih.gov/mesh/M0013595 http://id.nlm.nih.gov/mesh/M0556300
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001172Q000188 http://id.nlm.nih.gov/mesh/D061067Q000627 http://id.nlm.nih.gov/mesh/D008727Q000627 http://id.nlm.nih.gov/mesh/D018501Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D012720 http://id.nlm.nih.gov/mesh/D057915 http://id.nlm.nih.gov/mesh/D007596Q000187 http://id.nlm.nih.gov/mesh/D005492Q000627 http://id.nlm.nih.gov/mesh/D006304 http://id.nlm.nih.gov/mesh/D017211 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D001241Q000627 http://id.nlm.nih.gov/mesh/D061067Q000008 http://id.nlm.nih.gov/mesh/D000700Q000627 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D007275 http://id.nlm.nih.gov/mesh/D012074 http://id.nlm.nih.gov/mesh/D011239Q000627 http://id.nlm.nih.gov/mesh/D018501Q000008 http://id.nlm.nih.gov/mesh/D007596Q000503
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_db534dfb811794dcf8169959477d8ea5 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8214

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128121087 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128866026 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128812924

Total number of triples: 70.